Cargando…

High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease

Several prospective epidemiological studies have shown that there is a clear inverse relationship between serum high-density lipoprotein-cholesterol (HDL-C) concentrations and risk for coronary heart disease (CHD), even at low-density lipoprotein-cholesterol (LDL-C) levels below 70 mg/dL. However, m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosmas, Constantine E, Martinez, Ian, Sourlas, Andreas, Bouza, Kyriaki V, Campos, Frederick N, Torres, Verenisse, Montan, Peter D, Guzman, Eliscer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877920/ https://www.ncbi.nlm.nih.gov/pubmed/29623098 http://dx.doi.org/10.7573/dic.212525

Ejemplares similares

Primary genetic disorders affecting high density lipoprotein (HDL)
por: Kosmas, Constantine E, et al.
Publicado: (2018)

Novel lipid-modifying therapies addressing unmet needs in cardiovascular disease
por: Kosmas, Constantine E, et al.
Publicado: (2019)

The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease
por: Kosmas, Constantine E., et al.
Publicado: (2023)

Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus
por: Kosmas, Constantine E, et al.
Publicado: (2018)

Inclisiran: A New Promising Agent in the Management of Hypercholesterolemia
por: Kosmas, Constantine E., et al.
Publicado: (2018)

High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease
por: Ito, Fumiaki, et al.
Publicado: (2020)

Therapeutic management of hyperlipoproteinemia (a)
por: Kosmas, Constantine E, et al.
Publicado: (2019)

The Impact of Insulin Resistance and Chronic Kidney Disease on Inflammation and Cardiovascular Disease
por: Kosmas, Constantine E, et al.
Publicado: (2018)

Patient adherence, compliance, and perspectives on evolocumab for the management of resistant hypercholesterolemia
por: Kosmas, Constantine E, et al.
Publicado: (2018)

New and emerging lipid-modifying drugs to lower LDL cholesterol
por: Kosmas, Constantine E, et al.
Publicado: (2021)

Lipid-lowering interventions targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): an emerging chapter in lipid-lowering therapy
por: Kosmas, Constantine E, et al.
Publicado: (2017)

Safety and Tolerability of PCSK9 Inhibitors: Current Insights
por: Kosmas, Constantine E, et al.
Publicado: (2020)

Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia
por: Kosmas, Constantine E, et al.
Publicado: (2022)

Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL
por: Schekatolina, Svetlana, et al.
Publicado: (2022)

Inclisiran for the Treatment of Cardiovascular Disease: A Short Review on the Emerging Data and Therapeutic Potential
por: Kosmas, Constantine E, et al.
Publicado: (2020)

Insulin resistance and cardiovascular disease
por: Kosmas, Constantine E., et al.
Publicado: (2023)

Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression
por: Chalmers, Alexander D., et al.
Publicado: (2017)

HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role
por: Casula, Manuela, et al.
Publicado: (2021)

High-density lipoprotein cholesterol (HDL-C) in cardiovascular disease: effect of exercise training
por: Ahn, Nayoung, et al.
Publicado: (2016)

The pleiotropic vasoprotective functions of high density lipoproteins (HDL)
por: Boyce, Guilaine, et al.
Publicado: (2018)

Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
por: Rysz-Górzyńska, Magdalena, et al.
Publicado: (2016)

The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality
por: Cho, Kyung-Hyun
Publicado: (2022)

Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease
por: Gao, Shen, et al.
Publicado: (2017)

Anion Exchange HPLC Isolation of High-Density Lipoprotein (HDL) and On-Line Estimation of Proinflammatory HDL
por: Ji, Xiang, et al.
Publicado: (2014)

The Effect of Chia Seeds on High-Density Lipoprotein (HDL) Cholesterol
por: Dickens, Brian, et al.
Publicado: (2023)

Lipoprotein Glomerulopathy-Like Lesions in Atherosclerotic Mice Defected With HDL Receptor SR-B1
por: Liao, Jiawei, et al.
Publicado: (2021)

Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux
por: Navdaev, Alexei V., et al.
Publicado: (2020)

Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very‐Low‐Density Lipoproteins
por: Lawler, Patrick R., et al.
Publicado: (2017)

Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease
por: Patel, Parth N., et al.
Publicado: (2020)

Native High Density Lipoproteins (HDL) Interfere with Platelet Activation Induced by Oxidized Low Density Lipoproteins (OxLDL)
por: Badrnya, Sigrun, et al.
Publicado: (2013)

High-Density Lipoprotein (HDL) in Allergy and Skin Diseases: Focus on Immunomodulating Functions
por: Trakaki, Athina, et al.
Publicado: (2020)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017)

Microencapsulated Pomegranate Modifies the Composition and Function of High-Density Lipoproteins (HDL) in New Zealand Rabbits
por: Dorantes-Morales, Alan, et al.
Publicado: (2020)

High-Density Lipoprotein Nanoparticle Imaging in Atherosclerotic Vascular Disease
por: Leeper, Nicholas J., et al.
Publicado: (2017)

Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases
por: Ivanova, Ekaterina A., et al.
Publicado: (2017)

Oxidative modifications of foetal LDL-c and HDL-c lipoproteins in preeclampsia
por: León-Reyes, G., et al.
Publicado: (2018)

It’s Time to Reassess the High-Density Lipoprotein (HDL) Hypothesis: CSL112, a Novel Promising Reconstituted HDL Formulation
por: Marsche, Gunther
Publicado: (2015)

Association between ethnicity and obesity with high-density lipoprotein (HDL) function and subclass distribution
por: Woudberg, Nicholas J., et al.
Publicado: (2016)

High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol
por: Trajkovska, Katerina Tosheska, et al.
Publicado: (2017)

High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients
por: Tanaka, Sébastien, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2rv4g58c88jccm2mep0tqsir1t